Castle Biosciences Inc
CSTLNasdaqCIK 1447362HealthcareFiscal year ends Dec 31
Reports and events: 121 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-3016:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051052 |
| 2026-07-3016:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051045 |
| 2026-05-2916:14 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-039189 |
| 2026-05-0616:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031263 |
| 2026-05-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031255 |
| 2026-04-0810:13 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001628280-26-024166 |
| 2026-02-2616:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012272 |
| 2026-02-2616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-012263 |
| 2026-01-1309:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001909 |
| 2025-11-0316:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048254 |
| 2025-11-0316:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-048248 |
| 2025-08-0816:04 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001447362-25-000099 |
| 2025-08-0416:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001447362-25-000097 |
| 2025-08-0416:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-25-000096 |
| 2025-05-2316:39 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001447362-25-000085 |
| 2025-05-0516:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001447362-25-000069 |
| 2025-05-0516:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-25-000068 |
| 2025-04-0911:43 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001447362-25-000054 |
| 2025-02-2716:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001447362-25-000031 |
| 2025-02-2716:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-25-000030 |
| 2025-01-1306:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-25-000012 |
| 2024-11-0416:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001447362-24-000169 |
| 2024-11-0416:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-24-000168 |
| 2024-08-0516:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001447362-24-000122 |
| 2024-08-0516:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-24-000121 |
| 2024-05-2416:27 ET | 8-K | 5.07 Shareholder vote results | 0001447362-24-000072 |
| 2024-05-0216:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001447362-24-000060 |
| 2024-05-0216:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-24-000059 |
| 2024-04-1016:05 ET | DEF 14A | Proxy statementPeriod 2024-04-10 | 0001447362-24-000043 |
| 2024-03-2717:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-078933 |
| 2024-02-2816:08 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001447362-24-000017 |
| 2024-02-2816:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001447362-24-000016 |
| 2024-01-0807:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-24-000006 |
| 2023-11-0917:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-274634 |
| 2023-11-0216:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001447362-23-000147 |
| 2023-11-0216:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-23-000146 |
| 2023-08-0216:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001447362-23-000128 |
| 2023-08-0216:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-23-000127 |
| 2023-06-0506:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001447362-23-000097 |
| 2023-06-0116:16 ET | 8-K | 5.07 Shareholder vote results | 0001447362-23-000095 |
| 2023-05-0316:33 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001447362-23-000067 |
| 2023-05-0316:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-23-000065 |
| 2023-04-1216:06 ET | DEF 14A | Proxy statement | 0001193125-23-099178 |
| 2023-02-2817:17 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001447362-23-000038 |
| 2023-02-2816:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-23-000036 |
| 2023-01-2016:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001447362-23-000009 |
| 2023-01-0910:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001447362-23-000007 |
| 2022-12-2817:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001447362-22-000203 |
| 2022-12-1516:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001447362-22-000199 |
| 2022-11-0216:26 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001447362-22-000172 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:13 ET. Listed shows no prices and gives no investment advice.